NIH-funded research NIH-funded research

Targeting factors that help the heart and lungs adapt to low oxygen levels

Official title: Targeting Hypoxia-Inducible Factors (HIFs) for Heart and Lung Disease

Funded at University of Texas Hlth Sci Ctr Houston · NIH-11037681 · Data updated 2026-11-12

This study is looking at how certain proteins that help our bodies respond to low oxygen can be used to improve treatment for heart and lung diseases, especially during serious conditions like ARDS and heart attacks, so that patients can recover better.

More Hypoxia research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startMarch 1, 2025
Project endDecember 31, 2031
Funding year2025
Award (this year)$564,445
NIH project number1R35HL177402-01
Project IDNIH-11037681 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suffering from acute respiratory distress syndrome or other related heart and lung conditions.

Less likely to help

Patients with stable heart and lung conditions who do not experience acute episodes may not receive benefit from this research.

What this research studies

This research investigates how hypoxia-inducible factors (HIFs) can be targeted to improve outcomes in heart and lung diseases, particularly during conditions like acute respiratory distress syndrome (ARDS) and myocardial ischemia. The study focuses on understanding how these factors are stabilized during low oxygen levels and inflammation, and how they can help reduce excessive tissue damage. By exploring the roles of different HIF isoforms and their specific functions in various tissues, the research aims to develop new therapeutic strategies that could enhance patient recovery. Patients may benefit from insights gained into how to better manage their conditions through targeted therapies.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery and outcomes for patients with heart and lung diseases.

How similar studies have gone: Previous research has shown promising results in targeting hypoxia-inducible factors for therapeutic purposes, indicating potential for success in this approach.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Eltzschig, Holger K. — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Eltzschig, Holger K.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.